| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥12.3B | ¥17.2B | -28.7% |
| Operating Income | ¥-2.0B | ¥-0.5B | -296.0% |
| Ordinary Income | ¥-2.5B | ¥-0.6B | -342.9% |
| Net Income | ¥-2.9B | ¥-0.5B | -491.1% |
| ROE | -11.6% | -1.8% | - |
FY2026 Q3 results show significant performance deterioration: Revenue 1,230 million yen (YoY -28.7%), Operating Loss -198 million yen (versus prior loss of -50 million yen, deterioration of -296.0%), Ordinary Loss -248 million yen (versus prior loss of -60 million yen, deterioration of -342.9%), and Net Loss -292 million yen (versus prior loss of -50 million yen, deterioration of -491.1%). The precision equipment manufacturer recorded a gross profit of 165 million yen with gross margin of 13.4%, while SG&A expenses of 363 million yen resulted in substantial operating losses. Cash position stands at 531 million yen against total assets of 4,910 million yen, with equity of 2,518 million yen reflecting a decline in retained earnings from prior period.
Revenue declined 28.7% year-over-year to 1,230 million yen, representing a substantial contraction in top-line performance. As a single-segment precision equipment manufacturer, the revenue decline reflects either weakening customer demand, customer losses, or unfavorable product mix shifts. The gross profit margin of 13.4% indicates pricing pressure or elevated manufacturing costs relative to revenue. Cost of sales totaled 1,065 million yen, leaving limited gross profit to cover operating expenses.
From a profit perspective, SG&A expenses of 363 million yen represented 29.5% of revenue, creating significant fixed cost burden. The combination of revenue decline and high fixed cost structure resulted in operating leverage working in reverse, amplifying the operating loss to -198 million yen from -50 million yen in the prior year. Non-operating expenses of 63 million yen, including interest expense of 15 million yen, further deteriorated profitability to ordinary loss of -248 million yen. The gap between operating loss and net loss of 94 million yen reflects income taxes and adjustments, resulting in final net loss of -292 million yen. The pattern represents revenue down, profit down deterioration with intensifying losses driven by negative operating leverage and structural cost challenges.
[Profitability] ROE of -11.6% reflects substantial capital inefficiency driven by net loss, deteriorating from prior period positive territory. Operating margin of -16.1% indicates structural profitability challenges with SG&A expenses consuming gross profit entirely. Net profit margin of -23.8% represents severe bottom-line pressure. Gross margin of 13.4% remains below typical manufacturing benchmarks above 20%, suggesting pricing or cost structure issues. [Cash Quality] Cash and deposits of 531 million yen provide coverage of 2.12 times against short-term debt of 250 million yen, maintaining immediate liquidity. Inventories of 505 million yen represent 41.1% of revenue on annualized basis, indicating extended inventory holding periods. [Investment Efficiency] Total asset turnover of 0.25 times reflects low capital productivity. Inventory turnover period of 170 days and cash conversion cycle of 477 days indicate substantial working capital inefficiency, with cash tied up in receivables and inventories. [Financial Health] Equity ratio of 51.3% remains solid, though retained earnings declined 22.0% from 1,359 million yen to 1,061 million yen year-over-year, eroding equity base. Current ratio of 224.9% indicates adequate short-term coverage. Debt-to-equity ratio of 0.95 times appears manageable, though interest coverage of -12.82 times signals inability to service debt from operating profit, warranting close monitoring.
Cash and deposits of 531 million yen declined from prior period levels, though maintain coverage of 2.12 times against short-term borrowings. Working capital shows inefficiencies with accounts receivable of 192 million yen and electronically recorded monetary claims of 305 million yen representing extended collection periods. Inventory position of 505 million yen suggests production-demand misalignment or product obsolescence risk. On the liability side, electronically recorded obligations of 211 million yen and trade payables provide some supplier credit benefit. The combination of operating losses and extended working capital conversion suggests negative operating cash generation during the period. Total assets declined slightly to 4,910 million yen from 5,010 million yen, with non-current assets of 2,570 million yen including long-term loans payable of 642 million yen indicating multi-year debt obligations. The cash position provides near-term liquidity buffer, though sustained losses at current rate would gradually erode this cushion without operational improvements.
Ordinary loss of -248 million yen versus operating loss of -198 million yen indicates net non-operating expense contribution of approximately 50 million yen. This comprises primarily interest expense of 15 million yen plus other financial costs, representing the burden of debt servicing on an already negative operating base. Non-operating income remains minimal relative to operating losses, providing no meaningful offset. The negative interest coverage ratio of -12.82 times highlights that operating profit cannot service interest obligations, a critical earnings quality warning signal. With operating margin at -16.1% and net margin at -23.8%, the core business operations remain unprofitable before considering financial costs. The absence of disclosed operating cash flow data prevents verification of cash earnings quality, though the combination of operating losses and working capital buildup suggests weak cash generation. Earnings quality is materially impaired by structural operating losses rather than non-recurring items.
Full-year guidance projects revenue of 1,603 million yen, operating loss of -216 million yen, ordinary loss of -295 million yen, and net loss of -340 million yen with EPS of -54.61 yen. Q3 cumulative revenue of 1,230 million yen represents 76.7% progress against full-year guidance, tracking above standard 75% for Q3, though this reflects continued contraction with guidance anticipating further decline of -28.6% year-over-year for the full year. Operating loss progress of -198 million yen represents 91.7% of full-year loss guidance, suggesting Q4 may see modest improvement or stabilization. Net loss of -292 million yen represents 85.9% of full-year guidance of -340 million yen, indicating similar trajectory. The guidance assumes no dividend payment for the full year. Progress rates indicate that losses are materializing largely as anticipated in company projections, with limited scope for upside surprise given structural revenue weakness and fixed cost burden persisting through year-end.
Demand deterioration and product competitiveness erosion represent the primary risk, with revenue declining 28.7% year-over-year and full-year guidance anticipating similar contraction of -28.6%. The single-segment concentration in precision equipment manufacturing provides no diversification buffer against sector-specific weakness. Operating leverage amplifies revenue decline into disproportionate profit deterioration, with operating margin declining to -16.1% as SG&A expenses of 363 million yen remain elevated relative to shrinking revenue base. Inventory levels of 505 million yen combined with 170-day inventory turnover period raise obsolescence and write-down risk if demand fails to recover. The negative interest coverage ratio of -12.82 times indicates structural inability to service debt from operating profits, creating refinancing and covenant compliance risks despite currently manageable debt-to-equity of 0.95 times. Sustained losses erode retained earnings by 22.0% year-over-year, gradually weakening equity base and financial flexibility for future investments or downturns.
[Industry Position] (Reference - Proprietary Analysis)
The company's performance metrics fall substantially below manufacturing industry medians across profitability, efficiency, and growth dimensions. Operating margin of -16.1% compares unfavorably to industry median of 8.9% (IQR: 5.4% to 12.7%), placing the company in severe underperformance territory. Net profit margin of -23.8% versus industry median of 6.5% (IQR: 3.3% to 9.4%) similarly reflects structural profitability challenges. ROE of -11.6% substantially trails industry median of 5.8% (IQR: 3.1% to 8.4%), indicating capital is being destroyed rather than generating returns. Revenue growth of -28.7% significantly underperforms industry median of 2.8% (IQR: -1.5% to 8.8%), suggesting company-specific demand or competitive issues beyond normal industry conditions.
From an efficiency perspective, asset turnover of 0.25 times falls well below industry median of 0.56 times (IQR: 0.41 to 0.65), indicating poor capital productivity. Working capital metrics show particular weakness with inventory turnover of 170 days versus industry median of 112 days (IQR: 50 to 163 days), and operating working capital turnover approaching 477 days compared to industry median of 112 days (IQR: 72 to 144 days). This suggests substantial cash tied up in operations.
Financial health metrics provide mixed signals: equity ratio of 51.3% approximates industry median of 63.8% (IQR: 49.1% to 74.8%), maintaining adequate solvency positioning. Current ratio of 224.9% compares reasonably to industry median of 2.87 times (IQR: 2.13 to 3.84 times), preserving short-term liquidity. However, negative profitability metrics and deteriorating retained earnings suggest this financial cushion may erode without operational turnaround.
Overall industry positioning reflects bottom-quartile performance across operational metrics, with relative strength limited to balance sheet liquidity measures. The gap to industry medians is substantial and widening, indicating need for comprehensive restructuring.
(Industry: Manufacturing, N=105 companies, Period: 2025-Q3, Source: Proprietary Analysis)
Revenue contraction of 28.7% combined with structural operating losses and full-year guidance projecting continued decline signals fundamental business model stress requiring immediate operational intervention. The precision equipment manufacturing segment faces either end-market weakness, customer attrition, or competitive displacement that management guidance suggests will persist through fiscal year-end. Working capital inefficiencies with 170-day inventory turnover and 477-day cash conversion cycle indicate substantial opportunity for cash release through inventory optimization and receivables management, though execution risk remains high given current operational challenges. The negative interest coverage ratio of -12.82 times creates medium-term refinancing risk despite near-term liquidity appearing adequate, as sustained losses will eventually pressure both cash reserves and lender confidence absent clear turnaround trajectory.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.